171 related articles for article (PubMed ID: 9213009)
1. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
[TBL] [Abstract][Full Text] [Related]
2. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
Sass DA; Rucinski B; Bryer HP; Mann GN; Yuan Z; Ma Y; Jee WS; Epstein S
Bone; 1996 Oct; 19(4):381-6. PubMed ID: 8894144
[TBL] [Abstract][Full Text] [Related]
3. Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.
Mann GN; Sass DA; Chen HK; Buchinsky FJ; Bryer HP; Ma YF; Jee WS; Rucinski B; Epstein S
Calcif Tissue Int; 1996 Jul; 59(1):38-44. PubMed ID: 8661983
[TBL] [Abstract][Full Text] [Related]
4. The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine A-induced osteopenia in rats.
Sodam BR; Awumey EM; Sampson WH; Epstein S
Calcif Tissue Int; 2001 Feb; 68(2):117-21. PubMed ID: 11310347
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
Bryer HP; Isserow JA; Armstrong EC; Mann GN; Rucinski B; Buchinsky FJ; Romero DF; Epstein S
J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
Mann GN; Jacobs TW; Buchinsky FJ; Armstrong EC; Li M; Ke HZ; Ma YF; Jee WS; Epstein S
Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
8. The role of testosterone in cyclosporine-induced osteopenia.
Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin: a bone sparing immunosuppressant?
Romero DF; Buchinsky FJ; Rucinski B; Cvetkovic M; Bryer HP; Liang XG; Ma YF; Jee WS; Epstein S
J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
[TBL] [Abstract][Full Text] [Related]
10. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
Katz IA; Jee WS; Joffe II; Stein B; Takizawa M; Jacobs TW; Setterberg R; Lin BY; Tang LY; Ke HZ
J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
Joffe I; Katz I; Jacobs T; Stein B; Takizawa M; Liu C; Berlin J; Epstein S
Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
Bowman AR; Sass DA; Marshall I; Ma YF; Liang H; Jee WS; Epstein S
J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256
[TBL] [Abstract][Full Text] [Related]
14. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
[TBL] [Abstract][Full Text] [Related]
15. The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.
Yamamoto M; Markatos A; Seedor JG; Masarachia P; Gentile M; Rodan GA; Balena R
Calcif Tissue Int; 1993 Oct; 53(4):278-82. PubMed ID: 8275357
[TBL] [Abstract][Full Text] [Related]
16. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
Joffe I; Katz I; Sehgal S; Bex F; Kharode Y; Tamasi J; Epstein S
Calcif Tissue Int; 1993 Jul; 53(1):45-52. PubMed ID: 8348384
[TBL] [Abstract][Full Text] [Related]
17. Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat.
Rucinski B; Liu CC; Epstein S
Metabolism; 1994 Sep; 43(9):1114-8. PubMed ID: 8084286
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss.
Goodman GR; Dissanayake IR; Bowman AR; Pun S; Ma Y; Jee WS; Bryer HP; Epstein S
Bone; 2001 Jun; 28(6):583-8. PubMed ID: 11425645
[TBL] [Abstract][Full Text] [Related]
19. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
Epstein S; Dissanayake IR; Goodman GR; Bowman AR; Zhou H; Ma Y; Jee WS
Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
[TBL] [Abstract][Full Text] [Related]
20. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.
Cvetkovic M; Mann GN; Romero DF; Liang XG; Ma Y; Jee WS; Epstein S
Transplantation; 1994 Apr; 57(8):1231-7. PubMed ID: 7513912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
